Keyphrases
Antipsychotics
100%
Confidence Interval
53%
United States
42%
Attention Deficit Hyperactivity Disorder
39%
Hazard Ratio
38%
Schizophrenia
34%
Medicaid
28%
Nursing Homes
27%
Benzodiazepines
27%
Antipsychotic Use
26%
Population-based Cohort Study
25%
Older Adults
23%
Suicide
22%
Stimulants
22%
Second-generation Antipsychotics
21%
Pharmacoepidemiology
20%
Related Dementia
20%
Alzheimer's Dementia
20%
Mortality Risk
19%
Young People
18%
Odds Ratio
17%
Bipolar Disorder
16%
All-cause Mortality
15%
Medication Use
15%
Mental Disorders
15%
Risk Difference
15%
Comparative Effectiveness
15%
Disorders Diagnosis
14%
Quetiapine
14%
Adjusted Hazard Ratio
14%
Suicide Risk
14%
Patients with Schizophrenia
13%
Propensity Score
13%
Selective Serotonin Reuptake Inhibitors
12%
Risperidone
12%
Anxiety Disorders
12%
Stimulant Use
12%
Comparative Effectiveness Research
12%
Olanzapine
12%
Atypical Antipsychotics
11%
Confounding
11%
Alzheimer's Disease
11%
Pharmacological Treatment
11%
Adult Depression
11%
Cardiac Safety
11%
Medicaid Patients
11%
Medicare
10%
Central Nervous System Stimulants
10%
Drug Repurposing
10%
Alzheimer
10%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
58%
Cohort Study
32%
Benzodiazepine
26%
Alzheimer's Disease
25%
Attention Deficit Disorder
23%
Psychotropic Agent
18%
Selective Serotonin Reuptake Inhibitor
16%
Comorbidity
16%
Drug Repositioning
15%
Pandemic
15%
Congestive Heart Failure
14%
Anxiety Disorder
13%
Quetiapine
12%
Prevalence
12%
Diseases
11%
All Cause Mortality
11%
Standardized Mortality Ratio
11%
Clozapine
10%
Phosphodiesterase V Inhibitor
10%
Nesiritide
10%
Pharmacoepidemiology
10%
Hyperglycemia
10%
Drug Overdose
10%
Risperidone
9%
Heart Infarction
9%
Coronary Artery Disease
9%
Glucagon Like Peptide 1 Receptor Agonist
8%
Olanzapine
8%
Electronic Prescribing
8%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
7%
Antidepressant
7%
Cerebrovascular Accident
6%
Methylphenidate
6%
Mortality Rate
6%
Combination Therapy
6%
Disease Modifying Antirheumatic Drug
6%
Drug Approval
6%
Polypharmacy
6%
Antipsychotic Drug
6%
Carvedilol
6%
Stimulant
6%
Atomoxetine
6%
Verapamil
6%
Toxic Injury
6%
Tadalafil
5%
Prescription Drug
5%
Randomized Controlled Trial
5%
Sleep Disorder
5%
Sulfonylurea
5%
Rheumatoid Arthritis
5%
Medicine and Dentistry
Antipsychotic
30%
Attention Deficit Disorder
27%
Cohort Analysis
26%
Analeptic
24%
Alzheimer's Disease
21%
Medicare
21%
Nursing Home
21%
Odds Ratio
21%
Outpatient
17%
Adolescence
17%
Medicine
17%
Disease
16%
Drug Therapy
16%
Hazard Ratio
14%
Hyperglycemia
13%
Mental Disorder
12%
Atypical Antipsychotics
11%
Drug Repositioning
10%
Cardiovascular System
10%
Pharmacoepidemiology
10%
Health Care
9%
Diabetes
9%
Prevalence
8%
Atomoxetine
7%
Bipolar Disorder
7%
Proportional Hazards Model
7%
Population
6%
Anxiety Disorder
6%
Carvedilol
6%
Olanzapine
6%
Benzodiazepine
6%
Randomized Controlled Trial
5%
Depressive Disorder
5%
Rheumatoid Arthritis
5%
Inflammatory Arthritis
5%
Logistic Regression Analysis
5%
Adverse Drug Reaction
5%
Retrospective Cohort Study
5%
Patient Characteristics
5%
Substance Use Disorder
5%
Retrospective Study
5%
Substance Abuse
5%
Medical Care
5%
Standardized Mortality Ratio
5%
Systematic Review
5%
Cardiovascular Condition
5%
Hydroxychloroquine
5%
Meta-Analysis
5%
Phosphodiesterase V Inhibitor
5%
Sensorineural Hearing Loss
5%
